‘No going back’ for clinical trials after COVIDTrial sites have adapted swiftly to the restrictions of COVID-19, and patients have seen many knock-on benefits as Share X‘No going back’ for clinical trials after COVIDhttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/no-going-back-for-clinical-trials-after-covid/
Sensyne launches fundraising, agrees patient data deal with PhesiUK digital health firm Sensyne has secured access to millions more anonymised patent records via an alliance with Share XSensyne launches fundraising, agrees patient data deal with Phesihttps://pharmaphorum.com/news/sensyne-launches-fundraising-agrees-patient-data-deal-with-phesi/
Sensyne Health launches diabetes app in the UKUK digital health company Sensyne Health has launched a new smartphone app to help people across the diabetes Share XSensyne Health launches diabetes app in the UKhttps://pharmaphorum.com/news/sensyne-health-launches-diabetes-app-in-the-uk/
Few UK patients using digital products, despite doctors’ adviceFew patients in the UK are making use of digital products despite widespread backing from clinicians, according to Share XFew UK patients using digital products, despite doctors’ advicehttps://pharmaphorum.com/news/few-uk-patients-using-digital-products-despite-doctors-advice/
